Skip to content
Urogut In problems with urinary excretion due to benign prostatic hyperplasia (I to II degree according to Alken). Improves the complaints caused by an enlarged prostate without removing this enlargement.
Urogut 160 mg / 120 mg soft capsules. 1 capsule contains: 160 mg liquid extract of Sabal palm fruit (Sao Palmeto, Dwarf palm) and 120 mg dry nettle root extract.
Urogut 160 mg / 120 mg is a medicinal product of plant origin of the German pharmaceutical company Dr. Willmar Schwabe, indicated for long-term treatment of urinary complaints in mild to moderate benign prostatic hyperplasia (BPH). Urogut 160 mg / 120 mg is the only herbal medicine that combines the two special extracts from the fruits of sao palmetto (sabal) and nettle roots. The two ingredients complement each other synergistically, making it extremely effective in relieving both types of BPH symptoms; 1. irritative (due to irritation of the bladder) - frequent urination, nocturnal urination, painful urination, feeling of an empty bladder, imperative urge to urinate and 2.
The special extract of sao flame fruit (WS 1473) blocks testosterone-dependent prostate growth, and additional antispasmodic effects lead to relaxation of prostate and urethral muscle cells, improving urinary flow and relieving general complaints. It also contributes to the anti-inflammatory and anti-edematous effect.
It is extremely well tolerated and can be taken for a long time (over 2 years) without side effects on potency and libido. It can be combined with other medications
Urogut application
Dose 1 tablet 2 times a day. The duration of treatment is unlimited, but urological examination intervals should be observed according to the severity of the complaints.
This medicine only improves the complaints caused by an enlarged prostate without eliminating this enlargement. Therefore, it is recommended to consult a doctor for regular check-ups, especially if there is blood in the urine or acute urinary retention. If symptoms persist or worsen after taking the medicine, treatment should be re-evaluated.